Solstein Capital’s Sanofi SNY Stock Holding History

Solstein Capital’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-2,056	Closed	-$103K	–	193
2020 Q3	$103K	Hold	2,056	–	–	0.23%	89
2020 Q2	$105K	Hold	2,056	–	–	0.25%	75
2020 Q1	$90K	Buy	+2,056	New	+$98.4K	0.35%	48

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Solstein Capital's SNY Position: Q4 2020 in Review

Solstein Capital sold out of Sanofi (SNY) in Q4 2020, closing a stake of 2,056 shares — an estimated $103K sold.

Solstein Capital first reported a position in SNY in Q1 2020 and held it in 3 quarters. The position peaked at $105K in Q2 2020. 602 funds tracked by Wall St. Rank hold SNY as of Q4 2020.

Solstein Capital reported no remaining Sanofi position as of Q4 2020 after selling out during the quarter.
Solstein Capital sold 2,056 Sanofi shares in Q4 2020, an estimated $103K.
Solstein Capital first reported a position in Sanofi in Q1 2020 and held it in 3 quarters.
Solstein Capital's Sanofi position peaked at $105K in Q2 2020.
602 funds tracked by Wall St. Rank held Sanofi as of Q4 2020.

Based on Solstein Capital's 13F filing for Q4 2020, filed 11 Feb 2021.